Wednesday, October 26, 2016

El alendronato - maxibon 70 ( il ) , maxibon






+

El alendronato (a-LEN-droe-nate) MaxiBone 70 (IL) Nombres de marca EEUU: Binosto, Fosamax CAN: ACH-alendronato, Alendronato-70, Alendronato-FC, Apo-alendronato, Auro-alendronato, CO alendronato, Dom-alendronato, Fosamax, JAMP-alendronato, menta-alendronato, Mylan-alendronato, PHL - alendronato, PMS-alendronato, PMS-alendronato-FC, Q-alendronato, Ran-alendronato, relación de alendronato, Riva-alendronato, Sandoz-alendronato, Teva-alendronato INT: Mostrar / Ocultar Adronat (UA), Aldren 70 (PH, TH), Aldron (HR), Aldrox (CL), Alenato (AR), Alend (KR), Alendomax (JO), Alendovenir (IL), Alendra (PH), Alendrate (NZ), Alendrex (NZ), Alendro ( AU, SA), Alendro vez a la semana (KW), Alendrobell (UA), alendronato (TH), Alendros (KR), Alendroxl (PH), Alenfos (KR), Allentop (HK), Alovell (ID, PH, VN) , Arendal (PE), Armol (CR, DO, GT, HN, NI, PA, SV), Bifosa (EN), Bisbon (KR), Bonaid (KR), Bonalon (JP), Bonapex (EG), Bonmax ( JO), BonMax (TH), Calidron (JO), condensado (UA), Endronax (BR), Fonat (UA), Forosa (PH), Fosalan (IL), Fosamax (AE, AR, AT, AU, BB, BE, BG, BH, BM, BR, BS, BZ, CH, CL, CN, CY, CZ, DE, DK, CE, EE, EG, ES, FI, FR, GB, GR, GY, HK, recursos humanos, IE, IT, JM, JO, KR, KW, LB, MT, MX, NL, NO, NZ, PE, PK, PL, PR, PT, control de calidad, RO, RU, SA, SE, SG, SI, SK, SR, TH, TR, TT, TW, VE, VN), Fosamax vez a la semana (AE, BH, LB, SA), Fosmin (CE, PE), Fosval (PY), Gendarin (SE), Gubang (CN), Lendomax (AE), Malend (KR), Marvil (LB, PE, UY), MaxiBone (IL), MaxiBone 70 (IL), mAXLEN (TH), Nichospor (ID), Oseomax (CR, DO, GT, HN, NI, PA, SV), Oseotenk (AR), Osficar (CO), Ossmax (UA), Osteo-Plus (PH), Osteocor (PH), Osteodron (PH), Osteofar (ID), Osteofos (HK, IN) , Osteol (PY), OsteoMax (PH), Osteopor (UY), Osteosan (CL), Osteovan (CR), Osteve (LB), Ostex (CO), Porosal (VE), Reventa (PH), Tevanate (BG, TW), Valora (HR) Formas de esta droga El alendronato (líquido oral) El alendronato (píldora oral) medicamentos Prescrire para evitar




No comments:

Post a Comment